Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Erythrocyte complement receptor type 1 in non-SLE rheumatic diseases.

J H Yen¹, H W Liu, S F Lin

¹Department of Internal Medicine, Kaohsiung Medical College, Taiwan, Republic of China.

Rheumatology International

|January 1, 1990

Summary

Erythrocyte complement receptor type 1 (CR1) levels are significantly lower in patients with immune-mediated rheumatic diseases like ankylosing spondylitis and rheumatoid arthritis. CR1 levels did not correlate with disease activity in AS or RA, but showed a negative association with rheumatoid factor titer in RA.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Canregtools: a tool package for routine statistical analysis of Chinese population-based cancer registry data based on R language].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2025

Same author

[Investigation on awareness of the adjusted DTaP immunization schedule and its influencing factors among immunization service personnel in China in 2025].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025

Same author

[A case report on repairing hypopharyngeal defect and reconstructing pronunciation function using a free anterolateral thigh flap].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025

Same author

Experimental study of methane oxidation efficiency in three configurations of earthen landfill cover through soil column test.

Waste management (New York, N.Y.)·2024

Same author

[A study on the association between insulin resistance and genome-wide DNA methylation based on Shanghai monozygotic twins].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2024

Same author

<i>Limosilactobacillus reuteri</i> peptidoglycan alleviates aflatoxin B<sub>1</sub>-induced toxicity through adsorbing toxins and improving growth, antioxidant status, immunity and liver pathological changes in chicks.

British poultry science·2024

Area of Science:

Immunology
Rheumatology
Clinical Medicine

Background:

Erythrocyte complement receptor type 1 (CR1) plays a role in immune complex clearance.
Alterations in CR1 levels may be associated with rheumatic diseases.

Purpose of the Study:

To measure erythrocyte CR1 levels in patients with various rheumatic diseases.
To evaluate the clinical significance of erythrocyte CR1 in ankylosing spondylitis (AS) and rheumatoid arthritis (RA).

Main Methods:

Erythrocyte CR1 levels were quantified in 37 healthy controls and 106 patients with rheumatic conditions.
Statistical analyses were performed to compare CR1 levels and correlate them with clinical parameters.

Main Results:

Significantly decreased erythrocyte CR1 levels were observed in patients with AS, juvenile rheumatoid arthritis, Sjögren's syndrome, and RA.

Related Experiment Videos

No significant difference in CR1 levels was found in patients with gouty arthritis compared to controls.

In RA patients, erythrocyte CR1 levels showed a negative association with rheumatoid factor titer but were not correlated with disease activity or severity.

Conclusions:

Erythrocyte CR1 deficiency may be linked to immune-mediated rheumatic diseases.
CR1 levels do not appear to directly reflect disease activity in AS or RA.
Further research is warranted to explore the prognostic value of erythrocyte CR1 levels in RA.